JPH0253096B2 - - Google Patents
Info
- Publication number
- JPH0253096B2 JPH0253096B2 JP56183171A JP18317181A JPH0253096B2 JP H0253096 B2 JPH0253096 B2 JP H0253096B2 JP 56183171 A JP56183171 A JP 56183171A JP 18317181 A JP18317181 A JP 18317181A JP H0253096 B2 JPH0253096 B2 JP H0253096B2
- Authority
- JP
- Japan
- Prior art keywords
- gel
- phase
- emulsion
- liquid phase
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000839 emulsion Substances 0.000 claims description 32
- 239000003995 emulsifying agent Substances 0.000 claims description 21
- 229920002545 silicone oil Polymers 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 239000007789 gas Substances 0.000 claims description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 12
- 239000007791 liquid phase Substances 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 12
- 239000001301 oxygen Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000012071 phase Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- 239000000499 gel Substances 0.000 description 58
- 239000007788 liquid Substances 0.000 description 23
- 239000000463 material Substances 0.000 description 20
- -1 polydimethylsiloxanes Polymers 0.000 description 15
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 7
- 238000001471 micro-filtration Methods 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 125000006353 oxyethylene group Chemical group 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 238000003828 vacuum filtration Methods 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 238000011085 pressure filtration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000011362 coarse particle Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- XOKSLPVRUOBDEW-UHFFFAOYSA-N pinane Chemical compound CC1CCC2C(C)(C)C1C2 XOKSLPVRUOBDEW-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VINLJJIHDWAANV-UHFFFAOYSA-N 1,1,2,3,3,3-hexafluoro-2-[1,1,2,3,3,3-hexafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propoxy]propoxy]propan-1-ol Chemical compound OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(F)C(F)(F)F VINLJJIHDWAANV-UHFFFAOYSA-N 0.000 description 1
- FUUYWSGWIQRGAX-UHFFFAOYSA-N 1,2,2-triethyladamantane Chemical compound C1C(C2)CC3CC2C(CC)(CC)C1(CC)C3 FUUYWSGWIQRGAX-UHFFFAOYSA-N 0.000 description 1
- ODJQFZXHKPCJMD-UHFFFAOYSA-N 1,2,3,3a,4,5,6,7,8,8a-decahydroazulene Chemical compound C1CCCCC2CCCC21 ODJQFZXHKPCJMD-UHFFFAOYSA-N 0.000 description 1
- JDCMOHAFGDQQJX-UHFFFAOYSA-N 1,2,3,4,5,6,7,8-octafluoronaphthalene Chemical compound FC1=C(F)C(F)=C(F)C2=C(F)C(F)=C(F)C(F)=C21 JDCMOHAFGDQQJX-UHFFFAOYSA-N 0.000 description 1
- OJQMCPUPMPFAEF-UHFFFAOYSA-N 1,2,3,4,5,6,7-heptafluoro-8-(trifluoromethyl)naphthalene Chemical compound FC(F)(F)C1=C(F)C(F)=C(F)C2=C(F)C(F)=C(F)C(F)=C21 OJQMCPUPMPFAEF-UHFFFAOYSA-N 0.000 description 1
- VELCHXSEKJBSKL-UHFFFAOYSA-N 1,2-diethyladamantane Chemical compound C1C(C2)CC3CC1C(CC)C2(CC)C3 VELCHXSEKJBSKL-UHFFFAOYSA-N 0.000 description 1
- RTPQXHZLCUUIJP-UHFFFAOYSA-N 1,2-dimethyladamantane Chemical compound C1C(C2)CC3CC1C(C)C2(C)C3 RTPQXHZLCUUIJP-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- JTYRBFORUCBNHJ-UHFFFAOYSA-N 1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br JTYRBFORUCBNHJ-UHFFFAOYSA-N 0.000 description 1
- OWJREPNGCCZZCP-UHFFFAOYSA-N 1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8-pentadecafluorooctane Chemical compound FCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br OWJREPNGCCZZCP-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 description 1
- KHZZXWPFPVGNLK-UHFFFAOYSA-N 1-methyl-1-(1-methylcyclooctyl)cyclooctane Chemical class C1CCCCCCC1(C)C1(C)CCCCCCC1 KHZZXWPFPVGNLK-UHFFFAOYSA-N 0.000 description 1
- HKHYYCJEIGOYKL-UHFFFAOYSA-M 1-nonadecylidene-2h-pyridin-1-ium;acetate Chemical compound CC([O-])=O.CCCCCCCCCCCCCCCCCCC=[N+]1CC=CC=C1 HKHYYCJEIGOYKL-UHFFFAOYSA-M 0.000 description 1
- RSFSDWDJYPLKBN-UHFFFAOYSA-L 1-octadecylpyridin-1-ium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.CCCCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 RSFSDWDJYPLKBN-UHFFFAOYSA-L 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- RDBONSWKYPUHCS-UHFFFAOYSA-N 1-undecyl-4,5-dihydroimidazole Chemical compound CCCCCCCCCCCN1CCN=C1 RDBONSWKYPUHCS-UHFFFAOYSA-N 0.000 description 1
- PQMAKJUXOOVROI-UHFFFAOYSA-N 2,2,3,3,5,5,6,6-octafluoro-4-(trifluoromethyl)morpholine Chemical compound FC(F)(F)N1C(F)(F)C(F)(F)OC(F)(F)C1(F)F PQMAKJUXOOVROI-UHFFFAOYSA-N 0.000 description 1
- VHCKLBQLRHKFJW-UHFFFAOYSA-N 2,3,4-trifluoro-5-(1,1,2,2,3,3,4,4,4-nonafluorobutyl)furan Chemical compound FC=1OC(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)=C(F)C=1F VHCKLBQLRHKFJW-UHFFFAOYSA-N 0.000 description 1
- JRLAYDPTJWQPGP-UHFFFAOYSA-N 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol;octadecan-1-amine Chemical compound OCCOCCOCCOCCO.CCCCCCCCCCCCCCCCCCN JRLAYDPTJWQPGP-UHFFFAOYSA-N 0.000 description 1
- WEJWRPYVWRFROR-UHFFFAOYSA-N 2-aminoethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCN WEJWRPYVWRFROR-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- GWRHNZBWCXQDPH-UHFFFAOYSA-N 2-dodecyl-1,3,4-trimethylbenzene Chemical group CCCCCCCCCCCCC1=C(C)C=CC(C)=C1C GWRHNZBWCXQDPH-UHFFFAOYSA-N 0.000 description 1
- FKNCPNVBSHZODI-UHFFFAOYSA-N 2-ethyl-1,2-dimethyladamantane Chemical compound C1C(C2)CC3CC1C(CC)(C)C2(C)C3 FKNCPNVBSHZODI-UHFFFAOYSA-N 0.000 description 1
- FTSAVVYZFAIXIH-UHFFFAOYSA-N 2-ethyl-1-methyladamantane Chemical compound C1C(C2)CC3CC1C(CC)C2(C)C3 FTSAVVYZFAIXIH-UHFFFAOYSA-N 0.000 description 1
- WYRIQSJBDPBLDQ-UHFFFAOYSA-O 2-hydroxyethyl-dimethyl-[3-(octadecanoylamino)propyl]azanium Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CCO WYRIQSJBDPBLDQ-UHFFFAOYSA-O 0.000 description 1
- HNWNELAGDBSCDG-UHFFFAOYSA-O 2-hydroxyethyl-dimethyl-[3-(octadecanoylamino)propyl]azanium;nitrate Chemical compound [O-][N+]([O-])=O.CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CCO HNWNELAGDBSCDG-UHFFFAOYSA-O 0.000 description 1
- FUBFWTUFPGFHOJ-UHFFFAOYSA-N 2-nitrofuran Chemical class [O-][N+](=O)C1=CC=CO1 FUBFWTUFPGFHOJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UOKGBFGQRIWVQU-UHFFFAOYSA-N 3-methylbicyclo[3.3.1]nonane Chemical compound C1CCC2CC(C)CC1C2 UOKGBFGQRIWVQU-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- GWESVXSMPKAFAS-UHFFFAOYSA-N Isopropylcyclohexane Chemical compound CC(C)C1CCCCC1 GWESVXSMPKAFAS-UHFFFAOYSA-N 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- LTZZVMFKKKAAAZ-UHFFFAOYSA-N N'-octadecylethane-1,2-diamine trimethylazanium sulfate Chemical compound S(=O)(=O)([O-])[O-].C[NH+](C)C.C(CCCCCCCCCCCCCCCCC)NCCN.C[NH+](C)C LTZZVMFKKKAAAZ-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920001774 Perfluoroether Polymers 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical class C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- KTYVHLCLTPLSGC-UHFFFAOYSA-N amino propanoate Chemical compound CCC(=O)ON KTYVHLCLTPLSGC-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940088990 ammonium stearate Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical compound [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- WNTGVOIBBXFMLR-UHFFFAOYSA-N bicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1C2 WNTGVOIBBXFMLR-UHFFFAOYSA-N 0.000 description 1
- OOSCHYDNHHSIKU-UHFFFAOYSA-N bicyclo[4.3.2]undecane Chemical compound C1CC2CCCC1CCCC2 OOSCHYDNHHSIKU-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 1
- 229960000228 cetalkonium chloride Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- GFIQVRMNGWFIHW-UHFFFAOYSA-N dimethyl(octadecyl)sulfanium Chemical compound CCCCCCCCCCCCCCCCCC[S+](C)C GFIQVRMNGWFIHW-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- KSDGSKVLUHKDAL-UHFFFAOYSA-L disodium;3-[2-carboxylatoethyl(dodecyl)amino]propanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCN(CCC([O-])=O)CCC([O-])=O KSDGSKVLUHKDAL-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- ZUWJMSFTDBLXRA-UHFFFAOYSA-N hexadecanoic acid;sodium Chemical class [Na].CCCCCCCCCCCCCCCC(O)=O ZUWJMSFTDBLXRA-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IULGYNXPKZHCIA-UHFFFAOYSA-N octadecyl carbamate Chemical compound CCCCCCCCCCCCCCCCCCOC(N)=O IULGYNXPKZHCIA-UHFFFAOYSA-N 0.000 description 1
- BXXLBMBLLVIOKO-UHFFFAOYSA-N octadecylcarbamic acid Chemical class CCCCCCCCCCCCCCCCCCNC(O)=O BXXLBMBLLVIOKO-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- UJMWVICAENGCRF-UHFFFAOYSA-N oxygen difluoride Chemical class FOF UJMWVICAENGCRF-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- FYJQJMIEZVMYSD-UHFFFAOYSA-N perfluoro-2-butyltetrahydrofuran Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)OC(F)(F)C(F)(F)C1(F)F FYJQJMIEZVMYSD-UHFFFAOYSA-N 0.000 description 1
- LGUZHRODIJCVOC-UHFFFAOYSA-N perfluoroheptane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F LGUZHRODIJCVOC-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000002988 phenazines Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229930006728 pinane Natural products 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- OSIVISXRDMXJQR-UHFFFAOYSA-M potassium;2-[ethyl(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctylsulfonyl)amino]acetate Chemical compound [K+].[O-]C(=O)CN(CC)S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F OSIVISXRDMXJQR-UHFFFAOYSA-M 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- GIPRGFRQMWSHAK-UHFFFAOYSA-M sodium;2-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=CC=C1S([O-])(=O)=O GIPRGFRQMWSHAK-UHFFFAOYSA-M 0.000 description 1
- FGDMJJQHQDFUCP-UHFFFAOYSA-M sodium;2-propan-2-ylnaphthalene-1-sulfonate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(C(C)C)=CC=C21 FGDMJJQHQDFUCP-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- YFYABWXIJBTAAM-UHFFFAOYSA-M trimethyl(2-phenyltetradecan-2-yl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC(C)([N+](C)(C)C)C1=CC=CC=C1 YFYABWXIJBTAAM-UHFFFAOYSA-M 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/30—Materials not provided for elsewhere for aerosols
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2383/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen, or carbon only; Derivatives of such polymers
- C08J2383/04—Polysiloxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Colloid Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は気体運搬能力をもつた不活性フルオロ
カーボン又は低粘度シリコーン油をもとにしたゲ
ル組成物の製法に関する。本方法で生ずるゲルは
医学の用途をもつている。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a process for the preparation of gel compositions based on inert fluorocarbons or low viscosity silicone oils with gas transport capabilities. The gel produced by this method has medical uses.
気体運搬能力、即ち、酸素及び空気を含めた気
体混合物のような気体に対する高い溶解度をもつ
多くの不活性有機液体類が知られている。この様
な性質をもつ不活性有機液体の多くの種類の中
に、水と混ざらない液体フルオロカーボンと低粘
度シリコーン油がある。これらの種類の液体は、
好気性微生物を培養する為の1974年11月26日チバ
タ等に発行された合衆国特許第3850753号に記載
されている。しかし、この特許は乳濁液や乳濁液
とのゲル形成に言及していない。
Many inert organic liquids are known that have gas carrying capacity, ie, high solubility for gases, such as gas mixtures including oxygen and air. Among the many types of inert organic liquids with such properties are water immiscible liquid fluorocarbons and low viscosity silicone oils. These types of liquids are
No. 3,850,753, issued to Chibata et al. on November 26, 1974, for culturing aerobic microorganisms. However, this patent does not mention emulsions or gel formation with emulsions.
その他のベルフルオロカーボン類とその乳濁
液、及びそれらのものの性状が以下の合衆国特許
に記載されている。4220606、アール・イー・ム
ーア(R.E.Moore)、1980年9月2日;4143079、
アーム・イー・ムーア、1979年3月6日;
4105798、アール・イー・ムーア等、1978年8月
8日;4041086、ムーア等、1977年8月9日;
3911138、エル.シー.クラーク.ジユニア(L.
C.Clark Jr.)、1975年10月7日;3962439、ケイ.
ヨコヤマ(K.Yokoyama)等、1976年6月8
日;3993581、ケイ.ヨコヤマ等、1976年11月23
日;4187252、アール.ジエイ.ラゴウ(R.J.
Lagow)等、1980年2月5日;4110474、アー
ル.ジエイ.ラゴウ等、1978年8月29日;及び
3641167、ムーア等、1973年2月8日。1981年1
月26日の出願の出願番号第228642号に取つて代わ
られた1979年6月25日デビツツト.シー.ホワイ
ト(David C.Whith)により出願された、合衆
国特許出願番号第52041号に、やけどに液体フル
オロカーボンを直接又はスポンジに支持して、ま
たはフオーム、スプレー、ゲルの形で接触させる
というやけど等の傷の処置法が明らかにされてい
る。ホワイトの出願には、特定のゲル組成物やゲ
ル組成物の製法について開示がない。 Other perfluorocarbons and their emulsions and their properties are described in the following US patents: 4220606, REMoore, September 2, 1980; 4143079,
Arm E. Moore, March 6, 1979;
4105798, R.E. Moore et al., August 8, 1978; 4041086, Moore et al., August 9, 1977;
3911138, L. C. Clerk. Giunia (L.
C. Clark Jr.), October 7, 1975; 3962439, K.
K.Yokoyama et al., June 8, 1976
Day; 3993581, Kay. Yokoyama et al., November 23, 1976
Day; 4187252, R. J.A. Lagou (RJ
Lagow) et al., February 5, 1980; 4110474, R. J.A. Ragow et al., August 29, 1978; and
3641167, Moore et al., February 8, 1973. 1981 1
Debit, June 25, 1979, superseded by Application No. 228642, filed June 26, 1979. C. No. 52041, filed by David C.Whith, describes the application of liquid fluorocarbon to the burn directly or supported on a sponge, or in the form of a foam, spray, or gel. Treatment methods have been clarified. White's application does not disclose specific gel compositions or methods of making gel compositions.
上記の特許に含まれる情報は参照により本明細
書に参考に入れられる。 The information contained in the above patents is incorporated herein by reference.
種々の粒状材料をそれらが形成ないし処理され
る水性媒体から分離する技術が知られている。例
えば、合衆国特許第2107839号は、ラクツカ
(Lactuca)という植物の天然ラテツクスから導
かれる乾燥粉末型の治療剤の単離を記載している
が、これは乳濁液を放置して分離せしめ、次に活
性成分を含有する水溶液を分離するため瀘過また
は遠心分離するというものである。 Techniques are known for separating various particulate materials from the aqueous medium in which they are formed or processed. For example, U.S. Pat. No. 2,107,839 describes the isolation of a dry powder therapeutic agent derived from the natural latex of the Lactuca plant, which was prepared by leaving the emulsion to separate and then The process involves filtration or centrifugation to separate the aqueous solution containing the active ingredient.
更に沈殿、傾斜、瀘過(膜瀘過を含む)及び遠
心分離によつて水性懸濁液からつくられる種々の
ゲルが知られている。生成物は乾燥材料として普
通に単離され、水と接触すると半固体の幾分可塑
性又は膨潤状態に戻るのが明らかなため、「ゲル」
と呼ばれている。これらは高い多孔度を示し、そ
の起源、多孔度、膨潤度に応じて種々の目的にも
ちいられる。この様なざいりようの中に合衆国特
許第2824092号のゼラチン−カルボキシメチルセ
ルロース複合体;合衆国特許第3218307号の大豆
プロテイネートハイドロゲル;合衆国特許第
3096293号のように天然多糖類を醗酵させてから
遠心分離して得られるゼラチン状の固まり;合衆
国特許第3326890号のように瀘過及び遠心分離に
より安定な乾燥ハイドロコロイドとしてつくられ
るガラクトマンナン類のヒドロキシ低級アルキル
エーテル類;合衆国特許第3527712号の乾燥アガ
ロースゲル、及び合衆国特許第3346507号及び第
3560400号の通りにつくられるシリカゲルがある。 Additionally, various gels are known which are made from aqueous suspensions by sedimentation, decantation, filtration (including membrane filtration) and centrifugation. The product is commonly isolated as a dry material and appears to revert to a semi-solid, somewhat plastic or swollen state upon contact with water and is therefore termed a "gel".
It is called. They exhibit high porosity and are used for various purposes depending on their origin, porosity, and degree of swelling. Among these liquids are the gelatin-carboxymethylcellulose complex of U.S. Pat. No. 2,824,092; the soy protein hydrogel of U.S. Pat. No. 3,218,307;
A gelatinous mass obtained by fermenting natural polysaccharides and then centrifuging them as in US Pat. No. 3,096,293; hydroxy of galactomannans produced as stable dry hydrocolloids by filtration and centrifugation as in US Pat. No. 3,326,890. Lower alkyl ethers; dried agarose gels of U.S. Pat. No. 3,527,712 and U.S. Pat. Nos. 3,346,507 and
There is silica gel made as per No. 3560400.
しかし、これらの特許で、ゼラチン状材料の形
成に伴う乳濁液の濃縮を教示又は示唆するものは
なく、また不活性で水と混ざらない有機液体の気
体運搬剤を含有するゼラチン材料の製造を教示又
は示唆するものもない。 However, none of these patents teach or suggest the concentration of emulsions associated with the formation of gelatinous materials, nor do they teach or suggest the production of gelatinous materials containing an inert, water-immiscible organic liquid gas carrier. There is nothing to teach or suggest.
本発明に従つて、ガス運搬能力をもつた水非混
和性で不活性のフルオロカーボン又は低粘性シリ
コーン油と、水と、適当な乳化剤とを一緒にし、
一緒にした材料を乳化し、乳濁液を濃縮してゲル
相と液相とを生成させ、ゲルから液体を分離する
ことによつて、ゲル組成物を調製できることがわ
かつた。生ずるゲルは安定な組成物であり、皮膚
の刺激や傷、或いは酵素の様な気体を必要とする
あらゆる条件の処置用に例えば軟膏、膏薬等とし
て使用できる。ゲル型の気体運搬剤は、乳濁液に
比べ、単位容積当り気体運搬能力が遥かに大きい
という利点をもつている。これは本発明の結果、
大きな割合を占める気体非運搬性材料即ち水が除
かれているためである。
According to the invention, a water-immiscible inert fluorocarbon or low viscosity silicone oil with gas-carrying capacity is combined with water and a suitable emulsifier;
It has been found that gel compositions can be prepared by emulsifying the combined materials, concentrating the emulsion to form a gel phase and a liquid phase, and separating the liquid from the gel. The resulting gel is a stable composition that can be used, for example, as an ointment, salve, etc., for the treatment of skin irritations and wounds, or any condition requiring gases such as enzymes. Gel-type gas transport agents have the advantage of having a much greater gas transport capacity per unit volume than emulsions. This is a result of the present invention.
This is because a large proportion of non-gas transporting material, namely water, has been removed.
本明細書で使われるゲルという用語は、弾力性
で(ゼラチンのように)ゼリー状であるか、或い
は多少とも固めの、見掛け上均質な半固体物質で
ある。上に説明した特許の教示とは反対に、本発
明の「ゲル」は乾燥した粒状の多孔質形に戻ら
ず、水と接触して目に見えるほどの膨潤度を示さ
ない。従つて「ゲル」は本明細書でゼラチン状又
はゼリー状の性質というよりは一般的な意味で用
いられる。 The term gel, as used herein, refers to an apparently homogeneous semi-solid material that is elastic and jelly-like (as in gelatin) or more or less firm. Contrary to the teachings of the patents discussed above, the "gels" of the present invention do not revert to a dry, granular, porous form and do not exhibit any appreciable degree of swelling upon contact with water. Accordingly, "gel" is used herein in its general sense rather than in its gelatinous or jelly-like nature.
本明細書で用いられる「ベルフルオロカーボ
ン」とは、実質的に弗素化又は完全に弗素化され
た材料であつて、室温と大気圧で一般に液体であ
るが必ずしも液体でなくともよく、酸素や炭酸ガ
スのような気体を運搬する能力をもつている。 As used herein, "perfluorocarbon" refers to a substantially fluorinated or fully fluorinated material that is generally, but not necessarily, a liquid at room temperature and atmospheric pressure, and that is free of oxygen and carbon dioxide. It has the ability to transport gases such as gas.
本明細書の「実質的に弗素化された」とは、化
合物の水素原子のほとんどが弗素原子により、材
料の気体運搬能力がそれ以上の置換で実質的に増
えない程度まで置換されたことを意味する。水素
原子の少なくとも約80〜90%が弗素原子で置換さ
れたとき、この水準に到達するものと信ぜられ
る。上記の合衆国特許第3911138号及び合衆国特
許第4105798号で、酸素運搬能力は材料中に於け
る酸素などの気体の溶解度に関連づけられる。25
℃、水銀柱760mmで材料100c.c.当り10〜100c.c.の酸
素を過弗素化材料が吸収することとこれらの特許
は示唆している。しかし、水素原子の少なくとも
95%が置換されるのが好ましく、より好ましくは
少なくとも98%、最も好ましくは100%である。 As used herein, "substantially fluorinated" means that most of the hydrogen atoms of the compound have been replaced with fluorine atoms to the extent that further substitution does not substantially increase the gas carrying capacity of the material. means. It is believed that this level is reached when at least about 80-90% of the hydrogen atoms are replaced with fluorine atoms. In the above-mentioned US Pat. No. 3,911,138 and US Pat. No. 4,105,798, oxygen carrying capacity is related to the solubility of gases such as oxygen in the material. twenty five
These patents suggest that perfluorinated materials absorb between 10 and 100 c.c. of oxygen per 100 c.c. of material at 760 mm of mercury. However, at least the hydrogen atom
Preferably 95% is substituted, more preferably at least 98% and most preferably 100%.
本発明に使用するのに適したフルオロカーボン
は、環式のペルフルオロ炭化水素、又はそれらの
誘導体類として広く記載される材料である。その
例は化学的に不活性のC9〜C18多環式化合物類の、
例えばビシクロノナン類(例えばビシクロ
[3.3.1]ノナン、2,6−ジメチル−ビシクロ
[3.3.1]ノハナン又は3−メチルビシクロ
[3.3.1]ノナン)、アダマンタン、メチル及びジ
メチルアダマンタン、エチル及びジエチルアダマ
ンタン、テトラヒドロジシクロベンタジエン、メ
チル及びジメチルビシクロオクタン類、エチルメ
チルアダマンタン、エチルジメチルアダマンタ
ン、テトラヒドロビノル−S、メチルジアダマン
タン、トリエチルアダマンタン、トリメチルジア
ダマンタン、ピナン、カンフアン、1,4,6,
9−ジメタノデカリン、ビシクロ[4.3.2]ウン
デカン、ビシクロ[5.3.0]デカン等、又はそれ
らの任意の混合物の弗素化物である。ペルフルオ
ロカーボンのその他の例はペルフルオロトリブチ
ルアミン、ペルフルオロ−2−ブチルテトラヒド
ロフラン、ペルフルオロ−2−ブチルフラン、ペ
ルフルオロ−n−ヘプタン、ペルフルオロナフタ
リン、ペルフルオロ−1−メチルナフタリン、ペ
ルフルオロ−n−メチルモルホリン、及びペルフ
ルオロ−1−メチルデカリン、並びにペルフルオ
ロ(2,5,8−トリメチル−3,6,9−トリ
オキサ−1−ドデカノール)の1,2,2,2−
テトラフルオロメチルエーテルのようなペルフル
オロエーテル類を包含する。 Fluorocarbons suitable for use in the present invention are materials broadly described as cyclic perfluorohydrocarbons, or derivatives thereof. Examples are chemically inert C9 - C18 polycyclic compounds,
For example, bicyclononanes (e.g. bicyclo[3.3.1]nonane, 2,6-dimethyl-bicyclo[3.3.1]nohanane or 3-methylbicyclo[3.3.1]nonane), adamantane, methyl and dimethyladamantane, ethyl and diethyladamantane , tetrahydrodicyclobentadiene, methyl and dimethylbicyclooctanes, ethylmethyladamantane, ethyldimethyladamantane, tetrahydrobinol-S, methyldiadamantane, triethyladamantane, trimethyldiadamantane, pinane, camphuan, 1,4,6,
It is a fluorinated product of 9-dimethanodecalin, bicyclo[4.3.2]undecane, bicyclo[5.3.0]decane, etc., or any mixture thereof. Other examples of perfluorocarbons are perfluorotributylamine, perfluoro-2-butyltetrahydrofuran, perfluoro-2-butylfuran, perfluoro-n-heptane, perfluoronaphthalene, perfluoro-1-methylnaphthalene, perfluoro-n-methylmorpholine, and perfluoro-n-methylnaphthalene. -1-methyldecalin and 1,2,2,2- of perfluoro(2,5,8-trimethyl-3,6,9-trioxa-1-dodecanol)
Includes perfluoroethers such as tetrafluoromethyl ether.
上の材料の弗素原子のあるものは、臭素の様な
他のハロゲン原子で置換して良い。これらの化合
物には、例えば1−ブロモペンタデカフルオロ−
4−イソプロピルシクロヘキサン、1−ブロモト
リデカフルオロヘキサン、1−ブロモペンタデカ
フルオロオクタン及び1−ブロモペンタデカフル
オロ−3−イソプロピルシクロペンタンのような
モノ臭素化化合物類又はそれらのジ臭素化誘導体
類がある。 Some of the fluorine atoms in the above materials may be replaced with other halogen atoms such as bromine. These compounds include, for example, 1-bromopentadecafluoro-
Monobrominated compounds such as 4-isopropylcyclohexane, 1-bromotridecafluorohexane, 1-bromopentadecafluorooctane and 1-bromopentadecafluoro-3-isopropylcyclopentane or their dibrominated derivatives be.
過フツ素化されたC8又は低級の材料及びC18迄
ないしそれ以上の材料は、部分的に臭素化された
その類似体類を包含し、また、種々の異なるベル
フルオロ化合物類の混合物を本発明に使用でき
る。 Perfluorinated C 8 or lower materials and materials up to and above C 18 include partially brominated analogs thereof, and also include mixtures of a variety of different perfluorinated compounds. Can be used in the present invention.
室温で固体の場合の上の弗素化化合物類を、室
温で液体の他のペルフルオロカーボン等の適当な
溶媒に溶解し、生ずる混合物を使用して本発明の
乳濁液とゲルを形成させることが出来る。フルオ
ロカーボンを記載する時に本明細書で液体とは、
室温でそれ自体では液体であるフルオロカーボン
か、又はフルオロカーボン溶媒中に於ける固体フ
ルオロカーボンの溶液を意味する。 The above fluorinated compounds, which are solid at room temperature, can be dissolved in a suitable solvent, such as another perfluorocarbon, which is liquid at room temperature, and the resulting mixture can be used to form the emulsions and gels of the present invention. I can do it. When describing fluorocarbons, liquid herein means:
It refers to a fluorocarbon that is liquid by itself at room temperature, or a solution of a solid fluorocarbon in a fluorocarbon solvent.
合衆国特許第3850753号に記載のもののような
本発明に有用なシリコーン油は、約0.65ないし約
15センチボアズの粘度をもつべきである。このよ
うなシリコーン油としては、ダウ・コーニング・
コーポレーシヨン製の「DC−200−ICD」があ
る。これは分子量310、比重0.85、酸素溶解度は
25℃で液体100ml当り100mlである。ダウ・コーニ
ング・コーポレーシヨンから入手出来、本発明に
有用性を持つ他のシリコーン流体は、一般に
「DC−200」流体として記載されている。化学的
にはシリコーン油はポリジメチルシロキサン類あ
り、液体メチルシリコーン類としても知られてい
る。同様なシリコーン流体はゼネラル・エレクト
リツク社から入手できる。 Silicone oils useful in the present invention, such as those described in U.S. Pat. No. 3,850,753, have a range of
It should have a viscosity of 15 centiboaz. Examples of such silicone oils include Dow Corning,
There is "DC-200-ICD" manufactured by Corporation. This has a molecular weight of 310, a specific gravity of 0.85, and an oxygen solubility of
100 ml per 100 ml of liquid at 25°C. Another silicone fluid available from Dow Corning Corporation and having utility in the present invention is generally described as "DC-200" fluid. Chemically, silicone oils are polydimethylsiloxanes, also known as liquid methylsilicones. Similar silicone fluids are available from General Electric Company.
ゲル製造の第一段階で、不活性の気体運搬液体
を乳化剤の存在下に水中に乳化させる。乳化剤
は、水及びフルオロカーボン又は低粘度シリコー
ン油と混和させる時に有効な乳化とゲル安定性が
生ずるようなものを選ぶ。乳化剤は上記フルオロ
カーボン又は低粘度シリコー油と両立できるもの
で、ゲルが例えば人間の皮膚へ塗布された時に悪
影響を有しないものにすべきである。 In the first step of gel production, an inert gas-carrying liquid is emulsified in water in the presence of an emulsifier. The emulsifier is selected to produce effective emulsification and gel stability when mixed with water and the fluorocarbon or low viscosity silicone oil. The emulsifier should be compatible with the fluorocarbon or low viscosity silicone oil and should have no adverse effects when the gel is applied to, for example, human skin.
非イオン性乳化剤が、硬水でも軟水でも有効で
あり、PH依存性でないから好ましいが、イオン性
乳化剤も、陰イオン性、陽イオン性、両性であろ
うと使用できる。 Nonionic emulsifiers are preferred because they are effective in both hard and soft water and are not PH dependent, but ionic emulsifiers, whether anionic, cationic, or amphoteric, can also be used.
適当な非イオン性乳化剤はヘブチルフエノキシ
ポリエトキシエタノール、オクチルフエノキシボ
リエトキシエタノール、メチルオクチルフエノキ
シポリエトキシエタノール、ノニルフエノキシボ
リエトキシエタノール、ドデシルフエノキシポリ
エトキシエタノール等のような約7〜18個の炭素
原子のアルキル基と1〜60個以上のオキシエチレ
ン単位をもつアルキルフエノキシポリエトキシエ
タノール類;メチレン結合されたアルキルフエノ
ール類のポリエトキシエタノール誘導体類;1〜
60モル又はそれ以上のエチレンオキシドをノニ
ル、ドデシル、テトラデシル、t−ドデシル及び
同様なメルカプタン類と、又は6〜15個の炭素原
子のアルキル基をもつアルキルチオフエノール類
と縮合させてつくられるものなどの硫黄含有剤;
ラウリン酸、ミリスチン酸、バルミチン酸、オレ
イン酸等、又は分子当1〜60個のオキシエチレン
単位を含有するタル油中に見出されるような酸類
混合物等の長鎖カルボン酸類のエチレンオキシド
誘導体類;オクチル、デシル、ラウリル又はセチ
ルアルコールなど長鎖アルコールの類似のエチレ
ンオキシド縮合物;1〜60個のオキシエチレン単
位を含有するソルビタンモノステアレートのよう
な、疎水性炭化水素鎖をもつエーテル化又はエス
テル化されたポリヒドロキシ化合物のエチレンオ
キシド誘導体類;1〜60個のオキシエチレン基を
含有するドデシルアミン、ヘキサデシルアミン、
及びオクタデシルアミンのような長鎖又は分枝鎖
アミン類のエチレンオキシド縮合物;及び疎水性
プロピレンオキシド部分が1個ないしそれ以上の
親水性エチレンオキシド部分と結びついたものか
らなる、エチレンオキシドとプロピレンオキシド
とのブロツク共重合体を包含する。 Suitable nonionic emulsifiers include hebutylphenoxypolyethoxyethanol, octylphenoxypolyethoxyethanol, methyloctylphenoxypolyethoxyethanol, nonylphenoxypolyethoxyethanol, dodecylphenoxypolyethoxyethanol, etc. Alkylphenoxypolyethoxyethanols having an alkyl group of about 7 to 18 carbon atoms and 1 to 60 or more oxyethylene units; polyethoxyethanol derivatives of methylene-bonded alkylphenols; 1 to
Sulfur, such as those made by condensing 60 moles or more of ethylene oxide with nonyl, dodecyl, tetradecyl, t-dodecyl and similar mercaptans, or with alkylthiophenols having an alkyl group of 6 to 15 carbon atoms. Containing agent;
Ethylene oxide derivatives of long chain carboxylic acids such as lauric acid, myristic acid, balmitic acid, oleic acid, etc., or mixtures of acids such as those found in tall oil containing 1 to 60 oxyethylene units per molecule; octyl, Similar ethylene oxide condensates of long chain alcohols such as decyl, lauryl or cetyl alcohol; etherified or esterified with hydrophobic hydrocarbon chains such as sorbitan monostearate containing 1 to 60 oxyethylene units Ethylene oxide derivatives of polyhydroxy compounds; dodecylamine, hexadecylamine, containing 1 to 60 oxyethylene groups;
and ethylene oxide condensates of long-chain or branched-chain amines such as octadecylamine; and blocks of ethylene oxide and propylene oxide, consisting of a hydrophobic propylene oxide moiety combined with one or more hydrophilic ethylene oxide moieties. Including copolymers.
有用な陰イオン性乳化剤の例は、オレイン酸ナ
トリウム、パルミチン酸カリウム、ステアリン酸
アンモニウム、ラウリン酸エタノールアミン等を
含め、脂肪酸類のアルカリ金属塩、アンモニウム
塩及びアルカノールアミン塩のような通常石けん
類、並びにロジンと脱水されたロジン酸石けん
類、及びラウリル硫酸ナトリウム、セチル硫酸ナ
トリウム、スルホン化パラフイン油のナトリウム
塩、ドデカン−1−スルホン酸のナトリウム塩、
オクタデカン−1−スルホン酸等のナトリウム塩
のような高級脂肪族硫酸塩とスルホン酸塩を含め
た合成けん化材料;ナトリウムアルキルアリール
スルホネート類、例えばイソプロピルベンゼンス
ルホン酸ナトリウム、イソプロピルナフタリンス
ルホン酸ナトリウムのようなアルカリールスルホ
ネート類;及びナトリウムジオクチルスルホサク
シネート、ナトリウムN−オクタデシル−スルホ
ンサクシンアミド、分子当り1〜50個のオキシエ
チレン単位をもつスルホン化又は硫酸化アルキル
フエノキシエトキシエタノール類(ここでアルキ
ル基はヘキシル、n−オクチル、t−オクチル、
ラウリル、ヘキサデシル及びオクタデシルのよう
な4〜18個の炭素原子をもつもの)のような、ス
ルホン化ジカルボン酸エステル類とアミド類のア
ルカリ金属塩類を包含する。 Examples of useful anionic emulsifiers include common soaps such as alkali metal, ammonium and alkanolamine salts of fatty acids, including sodium oleate, potassium palmitate, ammonium stearate, ethanolamine laurate, etc. and rosin and dehydrated rosin acid soaps, sodium lauryl sulfate, sodium cetyl sulfate, sodium salt of sulfonated paraffin oil, sodium salt of dodecane-1-sulfonic acid,
Synthetic saponifying materials, including higher aliphatic sulfates and sulfonates, such as sodium salts of octadecane-1-sulfonic acid; sodium alkylaryl sulfonates, such as sodium isopropylbenzenesulfonate, sodium isopropylnaphthalene sulfonate, etc. alkaryl sulfonates; and sodium dioctyl sulfosuccinate, sodium N-octadecyl-sulfonesuccinamide, sulfonated or sulfated alkylphenoxyethoxyethanols with 1 to 50 oxyethylene units per molecule (where the alkyl group is hexyl, n-octyl, t-octyl,
Alkali metal salts of sulfonated dicarboxylic acid esters and amides, such as those having 4 to 18 carbon atoms such as lauryl, hexadecyl and octadecyl.
陽イオン性乳化剤はステアラミドプロピルジメ
チル−ベーターヒドロキシエチルアンモニウムジ
ハイドロジエンホスフエート、ステアラミドプロ
ピルジメチル−ベーターヒドロキシエチルアンモ
ニウムナイトレート、ステアログアナミン、ステ
アログアナミンエチレンオキシド反応生成物、オ
クタデシルカルバミン酸のオクタデシルアミン塩
及びエチレンオキシドと反応させたオクタデシル
カルバミン酸のオクタデシルグアナミン塩類、オ
クタデシルアミンテトラエチレングリコール、ロ
ジンアミンエチレンオキシド反応生成物等を包含
する。また、ウンデシルイミダゾリン及び、エチ
レンオキシドとプロピレンオキシドとの反応生成
物;オレイルアミノジエチルアミン塩酸塩;脂肪
酸と分解蛋白質との縮合生成物;モノステアリル
エチレンジアミントリメチルアンモニウムサルフ
エート;アルキルベンゼンイミダゾリン類、セチ
ルピリジニウムブロマイド、オクタデシルピリジ
ニウムサルフエート又はクロライド、オクタデシ
ルメチレンピリジニウムアセテート;ラウリルユ
リアエチレンオキシド;ジメチルオクタデシルス
ルホニウムのメチルサルフエート;ハロヒドリン
類とアミン類、ポリアミン類とアンモニアの縮合
物;アルキルホスホニウム化合物類、アルキルホ
スホニウムエチレンオキシド縮合物、エチレンオ
キシド及びプロピレンオキシドと縮合させたロジ
ンアミン類;セチルジメチルベンジルアンモニウ
ムクロライド、ジステアリルジメチルアンモニウ
ムクロライド、ステアリルジメチルベンジルアン
モニウムクロライド、n−アルキルジメチルベン
ジルアンモニウムクロライド、メチルドデシルベ
ンジルトリメチルアンモニウムクロライド、メチ
ルドデシルキシレンビス(トリメチルアンモニウ
ムクロライド)、セチルトリメチルアンモニウム
ブロマイド等を包含する。 Cationic emulsifiers include stearamidopropyl dimethyl-beta hydroxyethylammonium dihydrodiene phosphate, stearamidopropyl dimethyl-beta hydroxyethylammonium nitrate, stearaguanamine, stearaguanamine ethylene oxide reaction product, octadecylamine of octadecylcarbamate. Includes octadecylguanamine salts of octadecylcarbamic acid reacted with salts and ethylene oxide, octadecylamine tetraethylene glycol, rosinamine ethylene oxide reaction products, and the like. Also, undecylimidazoline and reaction products of ethylene oxide and propylene oxide; oleylaminodiethylamine hydrochloride; condensation products of fatty acids and decomposed proteins; monostearylethylenediamine trimethylammonium sulfate; alkylbenzene imidazolines, cetylpyridinium bromide, octadecyl Pyridinium sulfate or chloride, octadecylmethylene pyridinium acetate; lauryl urea ethylene oxide; methyl sulfate of dimethyl octadecyl sulfonium; condensates of halohydrins and amines, polyamines and ammonia; alkylphosphonium compounds, alkylphosphonium ethylene oxide condensates, ethylene oxide and Rosin amines condensed with propylene oxide; cetyldimethylbenzylammonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzylammonium chloride, n-alkyldimethylbenzylammonium chloride, methyldodecylbenzyltrimethylammonium chloride, methyldodecylxylene bis(trimethylammonium chloride) ), cetyltrimethylammonium bromide, and the like.
両性型乳化剤は、N−ココベータアミノプロピ
オネートのナトリウム塩、N−ココベータアミノ
プロピオン酸、ジナトリウムN−ラウリルベータ
−イミノジプロピオネート、ジカルボン酸ココナ
ツ誘導体ジエタノールアミン塩、ジカルボン酸パ
ルミチン酸誘導体ナトリウム塩、C−セチルベタ
イン、及びN−ラウリルベタインを包含する。 Amphoteric emulsifiers include sodium salt of N-cocobeta aminopropionate, N-cocobeta aminopropionic acid, disodium N-lauryl beta-iminodipropionate, diethanolamine salt of coconut derivative dicarboxylate, sodium palmitic acid derivative dicarboxylate. salts, C-cetylbetaine, and N-laurylbetaine.
弗素を含有する表面活性剤は、イオン性であろ
うと非イオン性であろうとあらゆる形式のものが
有用である。陰イオン型としてはアンモニウムパ
ーフルオロアルキルスルホネート類、カリウムパ
ーフルオロアルキルスルホネート類、カリウム弗
素化アルキルカルボキシレート及びアンモニウム
パーフルオロアルキルカルボキシレートがあげら
れる。非イオン型の例は弗素化アルキルエステル
類である。以上のものやその他の弗素含有表面活
性剤は、3M社から販売されている表面活性剤FC
−93、FC−95、FC−128、FC−143、FC−430、
及びFC−431のように市販のものである。 All types of fluorine-containing surfactants are useful, whether ionic or nonionic. Examples of the anionic type include ammonium perfluoroalkyl sulfonates, potassium perfluoroalkyl sulfonates, potassium fluorinated alkyl carboxylates, and ammonium perfluoroalkyl carboxylates. Examples of non-ionic types are fluorinated alkyl esters. These and other fluorine-containing surfactants are available from Surfactant FC, sold by 3M Company.
-93, FC-95, FC-128, FC-143, FC-430,
and commercially available products such as FC-431.
天然に生ずる乳化剤又はそれらの誘導体類も有
用である。これらはアルギネート類、メチルセル
ロース及びカルボキシメチルセルロースのような
セルロース誘導体類、アラビアゴム及びトラガカ
ントゴムのような水に溶けるゴム、燐脂質(レシ
チンなど)、及びステロール類を包含する。 Naturally occurring emulsifiers or their derivatives are also useful. These include alginates, cellulose derivatives such as methylcellulose and carboxymethylcellulose, water-soluble gums such as acacia and tragacanth, phospholipids (such as lecithin), and sterols.
好ましい乳化剤は非イオン性乳化剤のブルロニ
ツク(商標)F−68とプルロニツクF−108、及
びヨーク燐脂質である。ブルロニツク乳化剤はワ
イアンドツト−BASFから入手できるポリオキシ
エチレン類及びポリオキシプロピレン類である。
典型的には、乳化剤(非イオン性又はイオン性)
は全乳濁液組成物の約10重量%まで、又は乳濁液
の形成に使われる水に基づいて約5重量%までの
量で用いられる。所望により、それより多量を使
用できる。乳化剤は単独で、又はイオン的に両立
できることを条件として組合せて使用できる。 Preferred emulsifiers are the nonionic emulsifiers Bruronik F-68 and Pluronik F-108, and York phospholipids. Brulonik emulsifiers are polyoxyethylenes and polyoxypropylenes available from Wyndt BASF.
Typically an emulsifier (non-ionic or ionic)
is used in amounts up to about 10% by weight of the total emulsion composition, or up to about 5% by weight based on the water used to form the emulsion. Higher amounts can be used if desired. Emulsifiers can be used alone or in combination, provided that they are ionically compatible.
乳濁液及びゲルを形成させるのに使われる不活
性で有機の気体運搬液体、水及び乳化剤の量と割
合は広範囲にわたりうる。概して各成分の量は乳
濁液を形成させる量であり、過度の実験なしに当
業者が容易に決定できる。しかし、不活性フルオ
ロカーボン又は低粘性シリコーン油の好ましい濃
度は全組成物に基づいて約1重量%ないし約70重
量%、より好ましくは約10ないし約50重量%の範
囲にある。 The amounts and proportions of inert, organic, gas-carrying liquid, water, and emulsifier used to form emulsions and gels can vary widely. Generally, the amounts of each ingredient will form an emulsion and can be readily determined by one skilled in the art without undue experimentation. However, preferred concentrations of inert fluorocarbon or low viscosity silicone oil range from about 1% to about 70%, more preferably from about 10 to about 50% by weight, based on the total composition.
本発明の別の面として、ゲルを処理して未処理
の場合より多くの酵素を含有させることが出来
る。一つのこのような技術は、不活性フルオロカ
ーボン又は低粘度シリコーン油を他の材料と一緒
にする前に、これを追加の酸素と接触させること
である。例えば乳化前の不活性フルオロカーボン
又は低粘度シリコーワ油を760mmHgと等しいかそ
れより大きい圧力で100%酵素の環境におくとよ
い。その代りに、760mmHgに等しいかそれより大
きい圧力にある100%酵素の環境に生ずるゲルを
おくことによつても出来る。 Another aspect of the invention is that the gel can be treated to contain more enzyme than it would be untreated. One such technique is to contact the inert fluorocarbon or low viscosity silicone oil with additional oxygen before combining it with the other materials. For example, an inert fluorocarbon or low viscosity silicone oil prior to emulsification may be placed in a 100% enzyme environment at a pressure equal to or greater than 760 mm Hg. Alternatively, it can be done by placing the resulting gel in a 100% enzyme environment at a pressure equal to or greater than 760 mm Hg.
不活性フルオロカーボン又は低粘度シリコーン
油と水と乳化剤の混合物は、任意慣用のかきまぜ
手段により、例えば手動のかきまぜ、通気、プロ
ペラかきまぜ、タービンかきまぜ、コロイド混
合、均質化、高周波又は超音波発振(音波処理)
等によつて乳化される。ほとんどの場合、乳化は
室温で有効である。しかし、以上のかきまぜ手段
のあるものでは、乳濁液及び/又はゲル形成中に
過度の熱が発生し、既知の手段例えば冷却ジヤケ
ツトで除去される。種々のかきまぜ手段からの機
械的エネルギーの入力量は、例えば加工される材
料の量と使用設備に応じて実質的に変化する。 The mixture of inert fluorocarbon or low viscosity silicone oil, water and emulsifier may be prepared by any conventional agitation means, such as manual agitation, aeration, propeller agitation, turbine agitation, colloidal mixing, homogenization, radio frequency or ultrasonic oscillation (sonication). )
emulsified by etc. In most cases emulsification is effective at room temperature. However, with some of the above stirring means, excessive heat is generated during emulsion and/or gel formation and is removed by known means such as cooling jackets. The amount of mechanical energy input from the various stirring means varies substantially depending on, for example, the amount of material being processed and the equipment used.
本発明のゲル調整の第二段階では、乳濁液から
ゲル相と液相を形成する。この目的には例えば約
10000ないし20000rpmでの高速遠心分離(超遠心
分離)が有効である。速度の選択は乳濁液中のフ
ルオロカーボン又は低粘度シリコーン油の割合に
相応する(不活性フルオロカーボン又は低粘度シ
リコーン油が少なければ、速度は大きい)。その
結果、透明な上澄液と、容器底に沈む糊状固体
(ゲル相)ができる。 In the second step of gel preparation of the present invention, a gel phase and a liquid phase are formed from the emulsion. For this purpose, e.g.
High-speed centrifugation (ultracentrifugation) at 10,000 to 20,000 rpm is effective. The choice of speed depends on the proportion of fluorocarbon or low viscosity silicone oil in the emulsion (the less inert fluorocarbon or low viscosity silicone oil, the higher the speed). The result is a clear supernatant liquid and a pasty solid (gel phase) that settles to the bottom of the container.
第3三段階では、沈降、蒸発、傾斜、又は加圧
ろ過ないし真空ろ過のようなろ過によつてゲル相
と液相が分離される。分離はその後どんな処理が
必要かによつて部分的に又は完全にする。例えば
他の助剤を例えば抗菌剤、薬品、保湿剤、香料、
着色剤、化粧品化学者に知られたその他の添加物
をこの時点をゲルと混合したい場合は、幾分の液
をゲルと接触させておくのが好ましいかもしれな
い。他方、即時包装又は使用を考える場合には、
液の完全な分離が望ましいかも知れない。 In a third step, the gel and liquid phases are separated by sedimentation, evaporation, decanting, or filtration, such as pressure filtration or vacuum filtration. Separation can be partial or complete depending on what subsequent processing is required. For example, other auxiliaries such as antibacterial agents, drugs, moisturizers, fragrances, etc.
If it is desired to mix colorants or other additives known to cosmetic chemists with the gel at this point, it may be preferable to leave some liquid in contact with the gel. On the other hand, when considering immediate packaging or use,
Complete separation of the liquids may be desirable.
以上の第二及び第三段階の説明は、逐次的な濃
縮及び分離過程である。これらの段階はマイクロ
ろ過(限外ろ過ともいう)によつて同時的に実施
できる。しかし、マイクロろ過は1ミクロンより
大きいオーダーの比較的粗い粒度の乳濁液に対し
てのみ有効である。というのは、ほとんどの市販
のマイクロろ過膜は1ミクロンから約0.002ミク
ロンまでの見掛けの孔径をもつからである。この
ため、乳濁液粒子が微小な場合、マイクロろ過膜
を通過し分離されないためである。本発明の乳濁
液の多くは約0.1ないし約10ミクロンの範囲の粒
度をもつから、マイクロろ過はゲルを生成させる
ための乳濁液の濃縮と、生ずる上澄み液相からの
ゲル分離を同時に行う実際的な方法である。適当
なマイクロろ過膜は、例えば合衆国特許第
3615024号と第3856569号に記載のミリボア・カン
パニー及びアミコン・コーポレーシヨンから入手
できる生成物を包含する。 The above description of the second and third stages is a sequential enrichment and separation process. These steps can be carried out simultaneously by microfiltration (also called ultrafiltration). However, microfiltration is only effective for emulsions with relatively coarse particle sizes, on the order of greater than 1 micron. This is because most commercially available microfiltration membranes have apparent pore sizes from 1 micron to about 0.002 microns. For this reason, if the emulsion particles are minute, they will not pass through the microfiltration membrane and be separated. Since many of the emulsions of the present invention have particle sizes ranging from about 0.1 to about 10 microns, microfiltration simultaneously concentrates the emulsion to form a gel and separates the gel from the resulting supernatant liquid phase. This is a practical method. Suitable microfiltration membranes are described, for example, in U.S. Pat.
No. 3,615,024 and No. 3,856,569 available from Millibore Company and Amicon Corporation.
概して、ゲル生成と水相からのゲル分離を同時
にしたい時は、粗い乳濁液粒度が望ましい。次の
割合で成分を利用する時に、このような乳濁液が
形成される。 Generally, coarse emulsion particle size is desirable when simultaneous gel formation and gel separation from the aqueous phase is desired. Such emulsions are formed when utilizing the ingredients in the following proportions:
不活性フルオロカーボン又は低粘性シリコーン油
10〜50容量%
表面活性剤 2〜25重量%
水 25〜90重量%
不活性フルオロカーボン又は低粘度シリコーン
油及び表面活性剤の性質に応じて、上の割合はこ
れらの範囲から外に変化しうる。Inert fluorocarbon or low viscosity silicone oil
10-50% by volume Surfactant 2-25% by weight Water 25-90% by weight Depending on the nature of the inert fluorocarbon or low viscosity silicone oil and surfactant, the above proportions may vary outside these ranges. .
加圧又は真空ろ過、又は傾斜は、所望によりマ
イクロろ過と連携させて使用できる。真空ろ過中
に発泡しやすいため、加圧ろ過の方が真空ろ過よ
り好ましい。 Pressure or vacuum filtration or decanting can be used in conjunction with microfiltration if desired. Pressure filtration is preferable to vacuum filtration because foaming tends to occur during vacuum filtration.
所望により、抗細菌剤及び/又は抗生剤のよう
な抗微生物材料を本発明のゲルに取り入れること
ができる。抗細菌剤は、ゲルが多量の酸素を含む
ためゲルの存在下に増殖しうる好気性菌に対抗す
る。適当な抗細菌剤の例はキノリンカルボン酸、
ニトロフラン及びスルホンアミドを包含する。適
した薬剤はゲルに影響しないもの、或いは影響さ
れないものである。適当な抗生物質剤の例はアミ
ノグリオシド類、アンサマクロリド類、クロラム
フエニコール及びその類似体類、リンコサミニド
類、マクロリド類、ヌクレオキシ類、少糖類、ペ
プチド類、フエナジン類、ポリエン類、ポリエー
テル類、テトラサイクリン類その他を包含する。
以上の薬剤はエンサイクロペデイア・オブ・ケミ
カル・テクノロジー(Encyclopedia of
Chemical Technology)、第2巻752〜1036頁及
び第3巻7〜78頁(いずれも第3版)に詳細に記
載されている。上記薬剤は、ゲル製造の任意の段
階で、例えば乳化に先立つて液体成分への添加
(例えば水への溶解)により、乳化中又はあとで
乳濁液への分散により、又は分離後にゲルへの配
合によつて、ゲルへ取り入れられる。 If desired, antimicrobial materials such as antibacterial agents and/or antibiotics can be incorporated into the gels of the present invention. Antibacterial agents combat aerobic bacteria that can grow in the presence of gels because gels contain large amounts of oxygen. Examples of suitable antibacterial agents are quinoline carboxylic acid,
Includes nitrofurans and sulfonamides. Suitable agents are those that do not or are not affected by the gel. Examples of suitable antibiotic agents are aminogliosides, ansamacrolides, chloramphenicol and its analogues, lincosaminides, macrolides, nucleoxyls, oligosaccharides, peptides, phenazines, polyenes, polysaccharides, etc. Includes ethers, tetracyclines, and others.
The above drugs are listed in the Encyclopedia of Chemical Technology.
Chemical Technology), Vol. 2, pp. 752-1036 and Vol. 3, pp. 7-78 (both third editions). The agent may be added to the gel at any stage of the gel preparation, for example by addition to the liquid component prior to emulsification (e.g. by dissolution in water), by dispersion into the emulsion during or after emulsification, or into the gel after separation. Depending on the formulation, it can be incorporated into the gel.
生じるゲルは人間を含めた高等哺乳類の皮膚へ
塗布される軟膏として、傷、打撲傷、又は刺激の
処置法に使用できる。ゲルはまた手当用品中に生
成させる手当用品中にいれて、この手当用品中を
皮膚へ適用できる。本明細書で使用される「手当
用品」はガーゼ、バンテージ、外科用ラツピング
等のような、(傷口を含めて)ゲルと接触し、ゲ
ルをこのような接触に保持するのに適した任意の
材料を包含する。次の実施例は本発明の幾つかの
態様を例示しているが、添付の特許請求の範囲に
記載されたものを除き、その範囲を限定する意図
はもつていない。 The resulting gel can be used as an ointment applied to the skin of higher mammals, including humans, in the treatment of wounds, bruises, or irritations. The gel can also be incorporated into a dressing and applied to the skin in the dressing. As used herein, "dressing" means any suitable material for contacting and holding the gel in such contact (including at a wound), such as gauze, bandage, surgical wrapping, etc. Includes materials. The following examples illustrate some aspects of the invention and are not intended to limit its scope, except as described in the appended claims.
実施例 1
F−トリブチルアミン(ペルフルオロトリブチ
ルアミン)4g(2c.c.)、及びブルロニツクF68
乳化剤(平均分子量8380のエチレンオキシド−プ
ロピレンオキシド共重合体)5重量%を含有する
水18c.c.を試験官に入れた。音波処理によつてペル
フルオロカーボンを水中に均等に分散させた。乳
状の乳濁液を含有する試験官を10000rpmで10分
間遠心分離した。結果は透明な上澄液と底部の糊
状固体(ゲル)であつた。透明液を試験官から注
ぐとゲルが残つた。ゲルをスパーテルで試験官か
ら別の容器へ移した。ゲルは石油ゼリーの外観を
もち、重さ5gであつた。Example 1 4 g (2 c.c.) of F-tributylamine (perfluorotributylamine) and Bruronik F68
18 cc of water containing 5% by weight of an emulsifier (ethylene oxide-propylene oxide copolymer with an average molecular weight of 8380) was placed in the tester. The perfluorocarbon was evenly dispersed in the water by sonication. The tube containing the milky emulsion was centrifuged at 10000 rpm for 10 minutes. The result was a clear supernatant liquid and a pasty solid (gel) at the bottom. When the clear liquid was poured from the test tube, a gel remained. The gel was transferred from the test tube to another container with a spatula. The gel had the appearance of petroleum jelly and weighed 5 g.
エタノール5c.c.をゲルルに加えた。F−トリブ
チルアミン4g、即ち最初に乳濁液を形成するの
に用いた量が透明な液相として水−エタノール相
から分離し、このゲルが80重量%のフルオロカー
ボンを有することを示した。 5 c.c. of ethanol was added to the gel. Four grams of F-tributylamine, the amount originally used to form the emulsion, separated from the water-ethanol phase as a clear liquid phase, indicating that the gel had 80% by weight fluorocarbons.
エタノール使用を除いて上の手順を繰り返し、
分離したゲルを清潔な広口のジヤーに保持した。
75日後、ペルフルオロカーボンの水からの分離の
ような、ゲルの物理的外観に目に見える変化は認
められず、ゲルが安定であることを示した。 Repeat the above steps except using ethanol,
The separated gel was kept in a clean wide mouth jar.
After 75 days, there were no visible changes in the physical appearance of the gel, such as separation of perfluorocarbons from water, indicating that the gel was stable.
実施例 2
ブルロニツクF−68表面活性剤1.35gを水
25.65gに添加した。この水性混合物にF−トリ
ブチルアミン3c.c.(6g)を加えた。生じる組成
物を超音波処理すると、比較的粗い粒度(平均粒
度約1〜10ミクロン)の乳白色の乳濁液が生じ
た。見掛け孔径0.45ミクロンのミリポア(商標)
微孔質膜に乳濁液を通して窒素圧約25psig(1.756
Kg/cm2)下に瀘過した。ゲルが生成し、フイルタ
ー上に残つた。ゲルは貯蔵容器に容易に移しかえ
ることができた。Example 2 1.35 g of Bruronik F-68 surfactant was added to water.
Added to 25.65g. To this aqueous mixture was added 3 c.c. (6 g) of F-tributylamine. Sonication of the resulting composition resulted in a milky white emulsion with a relatively coarse particle size (average particle size of approximately 1-10 microns). Millipore (trademark) with apparent pore diameter of 0.45 microns
Pass the emulsion through the microporous membrane at a nitrogen pressure of approximately 25 psig (1.756 psig).
Kg/cm 2 ). A gel formed and remained on the filter. The gel could be easily transferred to a storage container.
実施例 3
F−トリブチルアミンの代りにF−トリメチル
ビシクロノナンを使用した以外は、あらゆる本質
的な点で実施例2と同じ調製技術を繰り返した。
本質的に同等な外観のゲルが得られた。Example 3 The same preparative technique as Example 2 was repeated in all essential respects, except that F-trimethylbicyclononane was used in place of F-tributylamine.
Gels of essentially equivalent appearance were obtained.
実施例 4
実質的に実施例1に記載の様に、水23.5c.c.と5
重量%ブルロニツクF−68乳化剤を含有する液体
を形成し、ゼネラルエレクトリツクシリコーンオ
イルSF96−50(2.5c.c.)を加え、乳白色乳濁液ま
で超音波処理することによつて乳濁液をつくつ
た。シリコーン油は粘度50cSt、比重0.963、引火
点460〓(237.8℃)及び流動点−67゜F(−55.0℃)
をもつ。次に乳濁液を14000rpmで20分遠心分離
すると、白色糊状ゲルが分離した。分離した流体
をゲルから傾斜させた。Example 4 23.5 cc of water and 5 cc of water were prepared substantially as described in Example 1.
An emulsion was made by forming a liquid containing % by weight Brulonik F-68 emulsifier, adding General Electric silicone oil SF96-50 (2.5 cc), and sonicating to a milky white emulsion. Silicone oil has a viscosity of 50 cSt, a specific gravity of 0.963, a flash point of 460〓 (237.8℃), and a pour point of -67゜F (-55.0℃).
have. The emulsion was then centrifuged at 14,000 rpm for 20 minutes, and a white pasty gel was separated. The separated fluid was decanted from the gel.
Claims (1)
ない、フルオロカーボン又は低粘度シリコーン
油、水、及び乳化剤をかきまぜ条件下に、乳濁
液の生成に有効な割合で混合して乳化させ、 (b) 乳濁液からゲル相と液相とを形成し、そして (c) 液相の全部又は一部をゲル相から分離する ことからなる、気体運搬用ゲル状組成物の製法。 2 ゲル相と液相との形成段階及び分離段階が逐
次的に行われる特許請求の範囲第1項に記載の製
法。 3 ゲル相と液相との形成段階が遠心分離によつ
て行われる特許請求の範囲第2項に記載の製法。 4 ゲル相と液相との形成段階と分離段階が同時
に行われる特許請求の範囲第1項に記載の製法。 5 ゲル相と液相との形成段階及び分離段階が、
乳濁液をマイクロフイルターに通すことによつて
行われる特許請求の範囲第4項に記載の製法。 6 ゲル形成中又は形成後に抗菌剤をゲルに混入
する特許請求の範囲第1項に記載の製法。 7 気体が酸素であり、ゲル調製の任意の段階中
又はその前に、酸素が該フルオロカーボン又は低
粘度シリコーン油へ導入される特許請求の範囲第
1項に記載の製法。 8 気体が酸素であり、酸素が液相の分離後にゲ
ル導入される特許請求の範囲第1項に記載の製
法。[Scope of Claims] 1 (a) An inert, water-immiscible fluorocarbon or low-viscosity silicone oil having gas-carrying capacity, water, and an emulsifier in a proportion effective to form an emulsion under stirring conditions. (b) forming a gel phase and a liquid phase from the emulsion; and (c) separating all or part of the liquid phase from the gel phase. Method of manufacturing the composition. 2. The manufacturing method according to claim 1, wherein the step of forming a gel phase and a liquid phase and the step of separating are performed sequentially. 3. The manufacturing method according to claim 2, wherein the step of forming the gel phase and the liquid phase is performed by centrifugation. 4. The manufacturing method according to claim 1, wherein the step of forming a gel phase and a liquid phase and the step of separating are performed simultaneously. 5. The formation step and separation step of the gel phase and the liquid phase are
The manufacturing method according to claim 4, which is carried out by passing the emulsion through a microfilter. 6. The manufacturing method according to claim 1, wherein an antibacterial agent is mixed into the gel during or after gel formation. 7. The method of claim 1, wherein the gas is oxygen and oxygen is introduced into the fluorocarbon or low viscosity silicone oil during or before any stage of gel preparation. 8. The method according to claim 1, wherein the gas is oxygen and the oxygen is introduced into the gel after separation of the liquid phase.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/418,428 US4443832A (en) | 1981-09-29 | 1982-09-15 | Self-illuminating ornament for vehicles |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20923880A | 1980-11-17 | 1980-11-17 | |
| US209238 | 1980-11-17 | ||
| US313124 | 1981-10-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5834033A JPS5834033A (en) | 1983-02-28 |
| JPH0253096B2 true JPH0253096B2 (en) | 1990-11-15 |
Family
ID=22777932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56183171A Granted JPS5834033A (en) | 1980-11-17 | 1981-11-17 | Production of gel having gas conveying property and said gel |
| JP62194570A Granted JPS63100928A (en) | 1980-11-17 | 1987-08-05 | Gel having gas transport property |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62194570A Granted JPS63100928A (en) | 1980-11-17 | 1987-08-05 | Gel having gas transport property |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS5834033A (en) |
| BE (1) | BE891141A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769241A (en) * | 1986-09-23 | 1988-09-06 | Alpha Therapeutic Corporation | Apparatus and process for oxygenation of liquid state dissolved oxygen-carrying formulation |
| DE10358306B8 (en) * | 2003-12-08 | 2005-03-03 | Coty B.V. | Cosmetic and dermatological oxygen carrier system, process for its preparation and its use |
| JP4851432B2 (en) * | 2007-12-12 | 2012-01-11 | 地方独立行政法人 東京都立産業技術研究センター | Volatile organic matter recovery processing apparatus and volatile organic matter recovery processing system having the same |
| MX2011005536A (en) * | 2008-11-25 | 2011-08-17 | Oxygen Biotherapeutics Inc | Perfluorocarbon gel formulations. |
-
1981
- 1981-11-16 BE BE0/206560A patent/BE891141A/en not_active IP Right Cessation
- 1981-11-17 JP JP56183171A patent/JPS5834033A/en active Granted
-
1987
- 1987-08-05 JP JP62194570A patent/JPS63100928A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63100928A (en) | 1988-05-06 |
| BE891141A (en) | 1982-05-17 |
| JPH0346169B2 (en) | 1991-07-15 |
| JPS5834033A (en) | 1983-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4569784A (en) | Preparation of a gel having gas transporting capability | |
| US4879062A (en) | Preparation of a gel having gas transporting capability | |
| JP4611741B2 (en) | Perfluorocarbon emulsion with non-fluorinated surfactant | |
| US3767788A (en) | Ophthalmic solution | |
| US3987163A (en) | Polystyrene sulfonate containing opthalmic solutions | |
| CA1216519A (en) | Perfluorochemical emulsion artificial blood | |
| KR100234547B1 (en) | Shampoo composition containing an oil-filled capsule | |
| EP0722313B1 (en) | Viscoelastic compositions of fluorinated organic compounds | |
| JPS61234928A (en) | Composition for cosmetics and skin comprising perfluoropolyether | |
| US5684050A (en) | Stable emulsions of highly fluorinated organic compounds | |
| US5556637A (en) | Water containing liposome system | |
| JPH10508316A (en) | Sterile ophthalmic gel formulation usable as drops and its manufacturing method | |
| CN113367997A (en) | Preparation method of oil-in-water Pickering emulsion containing ethanol, product and application thereof | |
| CA1257828A (en) | Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation | |
| US4029766A (en) | Protective antigen from pertussis, process for its preparation and products containing this antigen | |
| JPH0253096B2 (en) | ||
| GB2151203A (en) | Compositions for making vesicles | |
| US4917930A (en) | Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation | |
| CN114163660A (en) | Preparation method and application of graphene oxide modified carboxymethyl chitosan composite hydrogel | |
| JP3037994B2 (en) | Protein adsorption inhibitor on liposome surface | |
| JP2020506925A (en) | Topical composition | |
| US3325366A (en) | Biologically absorbable foam packing bandage and process therefor | |
| JPS59131684A (en) | Gel composition and manufacture of same at environmental temperature | |
| RU2777204C2 (en) | Method for production of ultrafine aqueous lyosols of turpentine oil with given particle sizes | |
| CN114796023A (en) | Oil-in-water snake oil microemulsion and preparation method thereof |